We are an emerging startup with a clear vision: to bridge health equity disparities and democratize healthcare access for early diagnoses and intervention for Alzheimer’s disease. Our core strategy revolves around developing low-cost, deployable diagnostic and intervention technologies. These innovations ensure that early detection and intervention are within reach for every community, regardless of their ethnicity, geographical location, or socioeconomic status. Our endeavor begins in Colombia, where a unique population's genetic predisposition to Alzheimer's provides a crucial insight into early detection and intervention pathways, holding a key to unlocking a potential cure for Alzheimer's. By establishing a sustainable clinical and research center in Colombia together with technology development partners in Switzerland, we set the stage for scientific discoveries that have the potential to reshape Alzheimer's care globally. Our team is a collective of dedicated product developers, neuroscientists, sleep experts, data analysts, and brain stimulation pioneers. We are passionate about combining the latest scientific advancements with a strong commitment to bring our solutions to everyone everywhere. The battle against Alzheimer’s is not just a scientific endeavor; it’s a call to arms for health equity. We invite investors, partners, and the global community to join us in this transformative venture. Together, we can redefine Alzheimer’s care, making a significant, sustainable impact on global health
